NASDAQ · DCOY

Decoy Therapeutics Inc.

Closing price · Nov 13, 2026 $0.9752

Latest quarter · ended Sep 30, 2026

Sales slipped and cash got weaker

descriptionFiled Nov 12, 2026
Revenue growth
—Sales for the quarter: $307K
Cash from operationsWorse
−$2.59M
Quarter ended Dec 31, 2024: −$743K cash from operationsQuarter ended Mar 31, 2025: −$1.18M cash from operationsQuarter ended Jun 30, 2025: −$862K cash from operationsQuarter ended Sep 30, 2025: −$1.65M cash from operationsQuarter ended Dec 31, 2025: −$1.14M cash from operationsQuarter ended Mar 31, 2026: −$2.89M cash from operationsQuarter ended Jun 30, 2026: −$2.65M cash from operationsQuarter ended Sep 30, 2026: −$2.59M cash from operations
Dec '24Sep '26
vs. −$1.65M a year ago
Share countBuying back
−59.3%
Quarter ended Dec 31, 2024: 1.75M sharesQuarter ended Mar 31, 2025: 2.13M sharesQuarter ended Jun 30, 2025: 7.65M sharesQuarter ended Sep 30, 2025: 5.86M sharesQuarter ended Dec 31, 2025: 531,968 sharesQuarter ended Mar 31, 2026: 531,968 sharesQuarter ended Jun 30, 2026: 655,185 sharesQuarter ended Sep 30, 2026: 2.39M shares
Dec '24Sep '26
2.39M shares vs. 5.86M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    1 real insider sale in 12 months. $17 in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

4 funds report owning DCOY, same as the quarter before

Holdings as of Jun 30, 2026
New2
Added0
Held0
Trimmed2
Sold out2

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Aug 31 · 14,000 sh · 6 peopleStock grant · Aug 31 · 8,116 sh · 2 peopleStock grant · Aug 31 · 33,455 shStock grant · Aug 31 · 9,682 shOpen-market sale · Dec 30 · $17
CEOCFOOther officersDirectorsDecFebAprJunAugOctStock grant · Aug 31 · 14,000 sh · 6 peopleStock grant · Aug 31 · 8,116 sh · 2 peopleStock grant · Aug 31 · 33,455 shStock grant · Aug 31 · 9,682 shOpen-market sale · Dec 30 · $17

Last 12 months. No real trades in the last 6.

Showing 1 real trade. Hidden: 10 stock grants. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Dec 30 Arnold Hanish Director Open-market sale $17 27 sh at $0.64 Sold 100% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in DCOY

As of Jun 30, 2026
FundOwnsValueChange
Vanguard Capital Management LLC0.2%$29KNew
Tower Research Capital LLC (trc)<0.1%$1.84K−75%
UBS Group AG<0.1%$180−95%
Caitong International Asset Management Co., Ltd<0.1%$14New

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist